Hepatitis C therapy with grazoprevir/elbasvir and glecaprevir/pibrentasvir in patients with advanced chronic kidney disease: data from the German Hepatitis C-Registry (DHC-R) : European Journal of Gastroenterology & Hepatology

Secondary Logo

Journal Logo

Original articles: Hepatology

Hepatitis C therapy with grazoprevir/elbasvir and glecaprevir/pibrentasvir in patients with advanced chronic kidney disease: data from the German Hepatitis C-Registry (DHC-R)

Stein, Kerstina; Stoehr, Albrechtb; Klinker, Hartwigc; Teuber, Gerlinded; Naumann, Uwee; John, Christinef; Heyne, Renateg; Serfert, Yvonneh; Niederau, Clausi; Zeuzem, Stefanj; Berg, Thomask; Wiegand, Johannesk;  German Hepatitis C-Registry

Author Information
European Journal of Gastroenterology & Hepatology 34(1):p 76-83, January 2022. | DOI: 10.1097/MEG.0000000000001923

Abstract

Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid